Characterization of the murine p19ARF promoter CpG island and its methylation pattern in primary lymphomas

被引:17
作者
Meléndez, B
Malumbres, M
Perez de Castro, I
Santos, J
Pellicer, A
Fernández-Piqueras, J
机构
[1] Univ Autonoma Madrid, Dept Biol, Lab Genet Mol Humana, E-28049 Madrid, Spain
[2] Ctr Nacl Invest Oncol Carlos III, Madrid 28220, Spain
[3] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain
[4] NYU, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA
[5] NYU, Dept Pathol, New York, NY 10016 USA
关键词
D O I
10.1093/carcin/21.4.817
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The INK4a/ARF locus encodes two different proteins involved in cell cycle control. Both molecules, p16(INK4a) and p19(ARF), inhibit cell cycle progression and have been shown to act as tumor suppressors in a variety of models, Their expression is controlled by separate promoters responding to different stimuli and they therefore show independent transcriptional regulation. We have cloned and characterized a 2.5 kb region upstream of the murine p19(ARF) gene to determine the role of DNA methylation in suppressing p19(ARF) transcription in a wide panel of murine primary T cell lymphomas, This region contains a DNA fragment with the characteristics of a CpG island similar to those described for the murine p16(INK4a) and p15(INK4b) genes, Expression of p19(ARF) is decreased in a significant number (20 %) of the murine lymphomas analyzed. Overexpression of the p19(ARF) transcript is also frequent, suggesting alterations in molecules of the retinoblastoma or p53 pathways that are involved in p19(ARF) regulation. Although hypermethylation of the INK4a and INK4b promoters is frequently involved in murine lymphomas, the p19(ARF) CpG island is infrequently methylated in the murine primary lymphomas studied in this work. Since loss of p19(ARF) expression cannot be explained as the result of homozygous deletions or hypermethylation of the ARF gene, other regulatory mechanisms seem to be altered in these malignancies.
引用
收藏
页码:817 / 821
页数:5
相关论文
共 40 条
[1]  
Antequera F., 1993, Experientia Supplementum (Basel), V64, P169
[2]   p14ARF links the tumour suppressors RB and p53 [J].
Bates, S ;
Phillips, AC ;
Clark, PA ;
Stott, F ;
Peters, G ;
Ludwig, RL ;
Vousden, KH .
NATURE, 1998, 395 (6698) :124-125
[3]   Frequent methylation silencing of p15INK4b (MTS2) and p16INK4a (MTS1) in B-cell and T-cell lymphomas [J].
Baur, AS ;
Shaw, P ;
Burri, N ;
Delacrétaz, F ;
Bosman, FT ;
Chaubert, P .
BLOOD, 1999, 94 (05) :1773-1781
[4]  
Baylin SB, 1998, ADV CANCER RES, V72, P141
[5]  
BRATHWAITE O, 1992, CANCER RES, V52, P3791
[6]   The INK4a/ARF tumor suppressor: one gene - two products - two pathways [J].
Chin, L ;
Pomerantz, J ;
DePinho, RA .
TRENDS IN BIOCHEMICAL SCIENCES, 1998, 23 (08) :291-296
[7]   E1A signaling to p53 involves the p19ARF tumor suppressor [J].
de Stanchina, E ;
McCurrach, ME ;
Zindy, F ;
Shieh, SY ;
Ferbeyre, G ;
Samuelson, AV ;
Prives, C ;
Roussel, MF ;
Sherr, CJ ;
Lowe, SW .
GENES & DEVELOPMENT, 1998, 12 (15) :2434-2442
[8]   CPG ISLANDS IN VERTEBRATE GENOMES [J].
GARDINERGARDEN, M ;
FROMMER, M .
JOURNAL OF MOLECULAR BIOLOGY, 1987, 196 (02) :261-282
[9]  
GONZALEZZULUETA M, 1995, CANCER RES, V55, P4831
[10]   GENETIC MECHANISMS IN TUMOR INITIATION AND PROGRESSION .4. MUTATIONAL ACTIVATION OF ONCOGENES IN ANIMAL-MODEL SYSTEMS OF CARCINOGENESIS [J].
GUERRERO, I ;
PELLICER, A .
MUTATION RESEARCH, 1987, 185 (03) :293-308